Emerging pharmacotherapies for the treatment of atrial fibrillation
Author:
Affiliation:
1. Department of Scienze Cardiovascolari, Clinica di Cardiologia Universita’ Politecnica delle Marche - Scienze Cardiovascolari, Ancona, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14728214.2018.1446941
Reference91 articles.
1. Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
3. Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation
4. Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Detection and modification of biomarkers of inflammation determining successful rhythm control in patients with atrial fibrillation;Biomarkers;2023-11-17
2. The Efficacy and Safety of Ivabradine in Arrhythmias: A Systematic Review;Pharmacy Practice;2023-10-05
3. Improvement of Vascular Insulin Sensitivity by Ranolazine;International Journal of Molecular Sciences;2023-08-31
4. What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria;The Journal of Physiology;2023-07-20
5. Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments;European Heart Journal Supplements;2023-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3